2020
DOI: 10.1016/j.ajg.2020.01.002
|View full text |Cite
|
Sign up to set email alerts
|

Multiple myeloma with primary amyloidosis presenting with digestive symptoms: A case report and literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
15
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(16 citation statements)
references
References 19 publications
0
15
0
1
Order By: Relevance
“…Noncardial clinical symptoms include generalized fatigue, purpura, sensorimotor polyneuropathy, carpal tunnel syndrome and lumbar spinal stenosis [ 1 ]. A growing body of evidence has highlighted a link between amyloidosis and MM, and an estimated rate of 10–15% of amyloidosis patients might develop MM [ 3 , 8 ]. The current therapeutic criteria for amyloidosis are based on the precursor-product concept.…”
Section: Discussion/conclusionmentioning
confidence: 99%
See 1 more Smart Citation
“…Noncardial clinical symptoms include generalized fatigue, purpura, sensorimotor polyneuropathy, carpal tunnel syndrome and lumbar spinal stenosis [ 1 ]. A growing body of evidence has highlighted a link between amyloidosis and MM, and an estimated rate of 10–15% of amyloidosis patients might develop MM [ 3 , 8 ]. The current therapeutic criteria for amyloidosis are based on the precursor-product concept.…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…A wide variety of treatments is available based on amyloidosis type. Concerning the MM, hematopoietic stem cell transplantation plays a pivotal role in the management [ 8 ]. Potential candidates to autologous stem-cell transplantation are treated initially with two to four cycles of nonmelphalan containing induction therapy [ 9 ].…”
Section: Discussion/conclusionmentioning
confidence: 99%
“…When the patient is asymptomatic, it is called smoldering MM (SMM). Approximately 10%-15% of MM patients develop overt AL[ 4 ]. However, there are few reports of MM coexisting with gastrointestinal AL[ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…Approximately 10%-15% of MM patients develop overt AL[ 4 ]. However, there are few reports of MM coexisting with gastrointestinal AL[ 4 ]. Moreover, there are only two reported cases of SMM combined with gastrointestinal AL to date[ 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Traditionally, MM has been estimated to be present in approximately 10–20% of AL patients [ 2 , 4 ]. The symptoms and signs of AL in patients with MM are different according to organs involved [4] .…”
Section: Introductionmentioning
confidence: 99%